Having a large clinical trial portfolio means giving patients treatment options often not available anywhere else, and years before they become the standard of care. To learn more about Karmanos Cancer Institute clinical trials or to see if a trial is right for you, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment below
  • DRITA Pilot Trial: Dietary Reporting In The Amyloidosis

    Cancer Categories
    • Hematologic (Blood Cancers)
    Karmanos Trial ID
    • 2022-067
    NCT ID
    • NCT05738005
    Age Group
    • Adult
    • Local
    PhaseClick for Clinical Trial Phase DefinitionQuestions, please contact us
    • N/A
    Principal Investigator
    • Jeffrey
      Zonder, M.D.

      Oncology - Hematology, Oncology - Medical View Profile


    Primary objective:

    • Assess the adherence rate of the use of the MyFitnessPal smartphone app during the second phase of trial participation in patients with amyloidosis.

    Exploratory objectives:

    • Explore associations between patient characteristics (demographics, health literacy, clinical characteristics, and perceptions) and the adherence during the second phase of trial participation.
    • Explore the association between the adherence during the second phase of trial participation and subsequent adherence.
  • Locations


    Karmanos Cancer Institute - Detroit Headquarters

    4100 John R
    Detroit, MI 48201
    Get Directions
    Phone: 800-527-6266

    Karmanos Cancer Institute at Weisberg Cancer Center - Farmington Hills

    31995 Northwestern Hwy
    Farmington Hills, MI 48334
    Get Directions
    Phone: 800-527-6266